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Abstract
Background: Freshwater cyanobacteria are common inhabitants of recreational waterbodies
throughout the world; some cyanobacteria can dominate the phytoplankton and form blooms,
many of which are toxic. Numerous reports in the literature describe pruritic skin rashes after
recreational or occupational exposure to cyanobacteria, but there has been little research
conducted on the cutaneous effects of cyanobacteria. Using the mouse ear swelling test (MEST),
we sought to determine whether three toxin-producing cyanobacteria isolates and the purified
cyanotoxin cylindrospermopsin produced delayed-contact hypersensitivity reactions.
Methods: Between 8 and 10 female Balb/c mice in each experiment had test material applied to
depilated abdominal skin during the induction phase and 10 or 11 control mice had vehicle only
applied to abdominal skin. For challenge (day 10) and rechallenge (day 17), test material was applied
to a randomly-allocated test ear; vehicle was applied to the other ear as a control. Ear thickness in
anaesthetised mice was measured with a micrometer gauge at 24 and 48 hours after challenge and
rechallenge. Ear swelling greater than 20% in one or more test mice is considered a positive
response. Histopathology examination of ear tissues was conducted by independent examiners.
Results: Purified cylindrospermopsin (2 of 9 test mice vs. 0 of 5 control mice; p = 0.51) and the
cylindrospermopsin-producing cyanobacterium C. raciborskii (8 of 10 test mice vs. 0 of 10 control
mice; p = 0.001) were both shown to produce hypersensitivity reactions. Irritant reactions were
seen on abdominal skin at induction. Two other toxic cyanobacteria (Microcystis aeruginosa and
Anabaena circinalis) did not generate any responses using this model. Histopathology examinations
to determine positive and negative reactions in ear tissues showed excellent agreement beyond
chance between both examiners (κ = 0.83).
Conclusion: The irritant properties and cutaneous sensitising potential of cylindrospermopsin
indicate that these toxicological endpoints should be considered by public health advisors and
reservoir managers when setting guidelines for recreational exposure to cyanobacteria.
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Background
Cyanobacteria, also known as blue-green algae, are com-
mon inhabitants of freshwater lakes and reservoirs
throughout the world. Under favourable conditions, cer-
tain cyanobacteria can dominate the phytoplankton
within a waterbody and form nuisance blooms. Anecdotal
and case reports have documented skin rashes associated
with contact exposure to freshwater cyanobacteria, from
recreational and occupational settings [1]. Some reports
and health advisories refer to irritant reactions [[2,3]
(p.32), [4]], but there are also convincing reports of
hypersensitivity reactions [5,6]. By way of contrast, some
cyanobacterial products appear to possess dermal anti-
inflammatory properties [7,8]. We present here the first
report of pathological effects on mammalian skin by the
alkaloid cyanotoxin cylindrospermopsin.
There is a small body of literature relating to research into
the cutaneous effects of planktonic freshwater cyanobac-
teria and the toxins of freshwater cyanobacteria. Human
clinical studies are discussed in the accompanying paper
by Stewart et al [9]. Only two reports referring to experi-
mental cutaneous reactions to toxic freshwater cyanobac-
teria using animal models were found in the literature:
van Hoof et al [10] reported no adverse effects in two
experiments involving rabbits and guinea pigs. Torokne et
al [11] suggest that exposure to heterotrophic bacterial
lipopolysaccharides may explain some of their positive
findings from non-axenic cynanobacterial preparations.
Krishnakumari et al [12] reported dermal testing of rats
with Spirulina platensis, a non-toxic cyanobacterium; no
signs of erythema or oedema were observed. Shirai et al
[13] describe an intraperitoneal induction and subcutane-
ous challenge test for delayed-type hypersensitivity in
mice, examining responses to non-toxic Microcystis  sp.,
with positive findings reported. Wannemacher et al [14]
used guinea pigs to determine acute dermal toxicity of
microcystin-LR (MC-LR) and saxitoxin, with dimethyl sul-
foxide (DMSO) as a vehicle. Dermal LD50s were report-
edly similar to or lower than rodent oral LD50s.
In their study of the cutaneous effects of axenic cyanobac-
teria, bloom samples and purified microcystin-LR,
Torokne et al [11] conducted intradermal irritancy tests on
rabbits; results were described as slight or negligible.
Guinea pig maximisation tests were used for DCH deter-
mination; the reported proportion of sensitised animals
ranged from 30% from two Microcystis blooms to 91%
from an Aphanizomenon bloom. A non-axenic C. raciborskii
preparation reportedly sensitised 50% of guinea pigs.
These proportions were applied to allergen rating scales of
"moderate allergen" for the Microcystis and C. raciborskii
preparations to "extremely strong allergen" for the Apha-
nizomenon preparation [11].
Some difficulties in interpreting this work come from the
reported percentages of sensitised guinea pigs, which are
not derivable from the reported number of animals tested.
Also, no details are given about the grading of end-points
(erythema and oedema) in either test animals or controls;
no photographic evidence of positive and negative reac-
tions was published. The authors noted that no irritant or
DCH effects were seen with axenic cyanobacterial prepa-
rations, and therefore concluded that the lipopolysaccha-
rides (LPS) of contaminating bacteria were implicated in
their positive findings from non-axenic cyanobacteria
[11]. The attribution of LPS involvement – cyanobacterial
or otherwise – in skin pathology is uncertain at best, and
the only references to reports of LPS-associated acute skin
rashes appear to be from the cyanobacteria literature, with
no specific research findings to support such attribution.
The topic of cyanobacterial lipopolysaccharides and their
pathogenicity was recently reviewed by Stewart et al [15].
If the findings of Torokne et al [11] can be repeated in
other laboratories, supporting evidence such as his-
topathological examination of challenged skin would be
helpful.
Shirai et al [13] describe an intraperitoneal induction and
subcutaneous challenge test for delayed-type hypersensi-
tivity, examining responses to non-toxic Microcystis bloom
samples and an axenic non-toxic culture of M. aeruginosa.
Mice were challenged two weeks after i.p. inoculation of
cells by s.c. injection into a rear footpad, and increases in
footpad thickness were measured. The authors report
induction of delayed-type hypersensitivity by this mouse
footpad swelling test, although it is not immediately clear
from the methods and reported results how the authors
demarcated irritant reactions from DCH reactions. Con-
trol mice reportedly showed increased footpad swelling,
although the report does not state which material was
administered to controls. We also have some concerns
regarding the method, as there is no description of how
footpad thickness was measured, and there was appar-
ently no injection of solvent into the contralateral foot-
pad, so it is not known whether or to what degree the
challenge injection procedure may have contributed to
footpad swelling [13].
Wannemacher et al [14] used guinea pigs to determine
acute dermal toxicity of microcystin-LR (MC-LR) and sax-
itoxin, as well as other eukaryotic algal toxins and T2
mycotoxin. Toxins were dissolved in dimethyl sulfoxide
(DMSO) and applied to shaved dorsal skin. The dermal
LD50s for saxitoxin and MC-LR were reported at 300 µg/kg
and 2 mg/kg respectively. These results are surprising,
given that oral LD50s for MC-LR are reported as ranging
from 3 mg/kg to 11 mg/kg in mice, and higher in rats
[16,17]. Oral LD50s for saxitoxin range from 64 µg/kg in
neonatal rats, to 530 µg/kg in adult rats, and 260 µg/kg inBMC Dermatology 2006, 6:5 http://www.biomedcentral.com/1471-5945/6/5
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mice [16]. The use of DMSO as a vehicle may have con-
tributed significantly to the trans-dermal transport of
these highly water-soluble toxins into the circulation,
hence the results of these experiments may not be readily
interpretable from a human health risk perspective.
Van Hoof et al [10] and Krishnakumari et al [12] appear to
have confused the concepts of irritancy and allergenicity
in their reports. Both studies apparently were not
designed to incorporate separate induction and challenge
phases to elicit delayed-contact hypersensitivity, i.e. they
were short-term tests for irritancy, yet the authors report
their findings (which were negative in each case) in terms
of DCH [10] and cutaneous allergy [12].
The MEST was chosen for these studies as a model to
investigate sonicated suspensions of lyophilised freshwa-
ter cyanobacteria, with the reported advantages over
guinea-pig models of cost-effectiveness, reduced test dura-
tion and objective data generation as opposed to visual
scaling [18]. Briefly, the procedure involves four applica-
tions of test material to the abdomen – the induction
phase – followed by challenge application to the ear. A
micrometer gauge is used to measure ear thickness; an
increase in ear swelling of 20 per cent or greater in one or
more test mice is regarded as a positive result [19]. Using
the MEST, we sought to determine whether three toxin-
producing cyanobacteria isolates and the purified cyano-
toxin cylindrospermopsin were capable of generating
delayed-contact hypersensitivity reactions.
Methods
Three sonicated cyanobacterial suspensions were tested by
separate MEST procedures:
• Microcystis aeruginosa - strain QH/NR/Ma/03/3 from the
Queensland Health Scientific Services Culture Collection.
This strain produces microcystins, predominantly micro-
cystin-LR (MC-LR). Microcystins are a group of >60 struc-
turally related cyclic peptide toxins; microcystins in this
suspension were measured at 13.6 mg/L total micro-
cystins expressed as MC-LR.
• Anabaena circinalis - strain AWQC Gar 311FR from the
Australian Water Quality Centre, Adelaide. This strain
produces saxitoxins, which are structurally related alka-
loid neurotoxins, measured at 6.0 mg/L total saxitoxins in
this suspension.
•  Cylindrospermopsis raciborskii strain AWT 205 isolated
and cultured from a Sydney ornamental lake [20] and
supplied by Dr Peter Hawkins of Australian Water Tech-
nologies, Sydney. This strain produces the alkaloid toxin
cylindrospermopsin, measured at 73 mg/L in this suspen-
sion.
Growth, harvesting, lyophilisation and storage of cells
were conducted as described in the accompanying paper
by Stewart et al [9]. A. circinalis was grown and harvested
as per M. aeruginosa cells in 20 L batch culture.
Cyanobacteria preparations were made by mixing 200 mg
lyophilised cells in 10 mL 70%v/v ethanol in Milli-Q® fil-
tered water to produce 2%w/v suspensions. Cell suspen-
sions were steeped overnight at 4°C. Cell integrity was
disrupted by subjecting each suspension to ultrasonic
pulsing for 30 seconds, using a Branson Ultrasonics Soni-
fier 450 instrument.
Saxitoxins were analysed by high performance liquid
chromatography (HPLC) with fluorescence detection
using a Shimadzu LC-10AVP system based on the meth-
ods of Lawrence et al [21]; microcystins were measured
using a Shimadzu LC-10A HPLC with photodiode array
detection using the methods of Lawton et al [22]. Cylin-
drospermopsin was quantified by HPLC-MS/MS with a
Perkin Elmer series 200 HPLC coupled to a PE SCIEX API
300 mass spectrometer [23].
Cylindrospermopsin was produced from strain AWT 205,
grown in continuous culture as described in Stewart et al
[9], isolated by solid phase extraction, purified by prepar-
ative HPLC and quantified by HPLC-MS/MS as described
above. Both 100 µg/mL and 50 µg/mL solutions in 70%v/
v ethanol/water were prepared.
A 0.1%w/v dinitrochlorobenzene (1-chloro-2,4-dini-
trobenzene, purchased from Sigma-Aldrich P/L) in 70%v/
v ethanol/water solution was used for a positive control
MEST. All suspensions and solutions were stored at -20°C
prior to use.
Specific-pathogen-free female Balb/c mice were supplied
by either Laboratory Animal Services, University of
Adelaide, or bred in-house at QHSS Biological Research
Facility. Mice were between 8 and 10 weeks of age, housed
in groups of five with free access to food and water. Stand-
ard rodent chow enriched with vitamin A acetate 250 IU/
g (Glen Forest Stock Feeds, Western Australia) was sup-
plied for two weeks prior to testing and throughout the
duration of each experiment. Following removal of
abdominal fur all mice received bilateral intradermal
injections of Freund's complete adjuvant (Sigma-Aldrich
P/L). Abdominal and ear skin was dried with a domestic
mains-powered hair dryer after application of test materi-
als and vehicle controls. Ear thickness was measured with
a micrometer gauge (Model 2046 F, Mitutoyo Corp.,
Tokyo).BMC Dermatology 2006, 6:5 http://www.biomedcentral.com/1471-5945/6/5
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The MEST experiments for DCH were conduced according
to the methods of Gad [19], with the following modifica-
tions:
1. The test ear of each mouse was randomly assigned as
either the left or right ear. This simple modification
should increase the reliability of the model by allowing
the investigator to be blinded to the identity of test ears,
provided that test materials do not affect the colour of test
solutions.
2. Individual mice were identified by tail markings using
a permanent marker pen. This is necessary for research
purposes in order to allow random allocation of test ears,
and for histopathological examination of ears.
3. Abdominal fur was removed with a proprietary depila-
tory cream (Nair brand. Active ingredient: calcium thi-
oglycolate <10%w/w). Tape stripping to remove the
stratum corneum was performed on days 1, 3 and 5 (i.e.
tape-stripping was not conducted on day 0, after depila-
tory treatment).
4. Mice were anaesthetised for ear thickness measure-
ments with a 50:50 mixture of CO2 and O2, as described
by Blackshaw & Allan [[24] (p.73)].
5. Pre-test screens for irritancy were not conducted in
order to reduce the number of animals used. Scoping
experiments on mice conducted in our laboratory to
investigate irritancy and to familiarise ourselves with the
MEST techniques led us to suspect that toxic M. aeruginosa
and non-toxic A. circinalis would not initiate irritant
responses when administered at high concentrations
(data not shown).
At least two, and more frequently three micrometer read-
ings were taken on each ear, depending on the time that
each mouse remained motionless after CO2/O2 anaesthe-
sia. The average of the two or three readings taken on each
ear was used to determine differences in ear thickness
between test ears and control ears. Percent ear swelling at
each measurement period was determined by the for-
mula: % ear swelling = 100*(A-B)/B where A denotes the
mean test ear thickness and B denotes the mean control
ear thickness.
All challenge and rechallenge concentrations were the
same as for the induction doses (2%w/v lyophilised
cyanobacteria in 70%v/v ethanol), with the exception of
the cylindrospermopsin MEST. In this test, the challenge
dose was 20 µL to the ventral pinna and 20 µL to the dor-
sal pinna of each test ear using a 50 µg/mL CYN in 70%
ethanol solution, i.e. half the concentration of the induc-
tion dose. CYN rechallenge doses were performed with
the normal induction concentration of 100 µg/mL CYN in
70% ethanol.
Histopathology
Mice were sacrificed by CO2 inhalation; ears from five test
mice and five control mice in the CYN MEST were
removed and fixed in 10% phosphate-buffered formalin.
Ears from test mice that produced positive MEST
responses were selected for histopathology examination.
Ears from test mice in the C. raciborskii MEST were not
considered in this examination as these mice were sub-
jected to ear thickness measurements beyond day 19, i.e.
past the 48-hour post-rechallenge period, in order to
monitor their return to baseline. However, ears from three
C. raciborskii MEST control mice were collected after the
48-hour post-challenge measurements and prepared on
microscopy slides. Ears from two mice in the A. circinalis
and M. aeruginosa MESTs were also collected. Liver, kid-
ney, spleen and lung tissue were harvested from three
mice that were peak responders in each of the C. raciborskii
and CYN MESTs; these organs were fixed as for ears. Tissue
slices were stained with haematoxylin and eosin and
mounted on glass slides for microscopic examination.
Two examiners conducted histopathological examina-
tions: 1st examiner was author AAS; 2nd examiners were an
expert pathologist with specific expertise in pathology of
the skin, plus a consultant dermatologist and three der-
matology registrars. 2nd examiners reported each slide by
consensus. Histopathological examination was con-
ducted by presenting each pathologist with identified
slides from one control ear and two test ears from the pos-
itive control MEST (0.1% DNCB) to allow for familiarisa-
tion with normal mouse ear morphology and type-IV
hypersensitivity-related changes. All subsequent slides
were read with the examiners blinded to their identity.
Statistical analyses
Fisher's exact test was used to compare proportions of test
ear increases greater than 20% between test and control
mice. Histopathology inter-rater agreement was assessed
using Cohen's kappa (K) statistic. Fisher's exact test was
used to examine the marginal homogeneity of the pathol-
ogist responses by comparing the unmatched distribution
of equivocal / normal / positive ratings. Statistical tests
were performed with SPSS v.13.0, and p < 0.05 was used
to denote statistical significance.
Ethical approval
QHSS Animal Ethics Committee granted approvals for the
original study protocol and all subsequent amendments
under clearance number NRC 3/98/20 IS.BMC Dermatology 2006, 6:5 http://www.biomedcentral.com/1471-5945/6/5
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Results
MESTs for delayed-contact hypersensitivity
Ear thickness increases, expressed as percent ear swelling,
for the four cyanobacterial MESTs (M. aeruginosa, C. raci-
borskii, A. circinalis and purified cylindrospermopsin) and
the positive control MEST (0.1% DNCB) are given in
Table 1. Figures 1, 2, 3 are point plots showing ear thick-
ness changes of individual mice in MESTs for DNCB, C.
raciborskii and CYN. All mice dosed with DNCB registered
ear thickness increases greater than 20%. Test ears were
erythematous; some had obvious oedema. No mice dosed
with 2%w/v suspensions of A. circinalis or M. aeruginosa
reached 20% ear swelling. The MEST using a 2%w/v sus-
pension of C. raciborskii containing 73 µg/mL cylindros-
permopsin (CYN) resulted in a clear median increase in
ear swelling of test animals; eight of ten test mice pro-
duced ear thickness increases of greater than 20% at chal-
lenge and/or rechallenge; no control mice gave ear
thickness increases of >20%. The MEST for purified CYN
produced ear thickness increases greater than 20% in two
of nine test mice and none of five control mice following
challenge doses of 50 µg/mL CYN. After rechallenge with
100 µg/mL CYN, four test mice and one of six control
mice had ear thickness readings of >20%.
Induction-phase reactions – C. raciborskii suspension and 
CYN
As well as the ear thickness changes given in Table 1 and
Figures 2 and 3, primary irritant reactions were seen on
the abdominal skin of mice tested with the C. raciborskii
suspension, and with purified CYN. No signs of irritancy
were seen on the abdominal skin of mice treated with sus-
pensions of M. aeruginosa or A. circinalis, or DNCB solu-
tion. The reaction seen on C. raciborskii and CYN-treated
mice occurred on all test mice with varying degrees of
severity. Figure 4 shows a test mouse with this reaction.
Figure 5 shows a control mouse for comparison; vehicle
only (70%v/v ethanol/water) was applied to the abdomi-
nal skin of control mice.
Lesions produced on abdominal skin were noted from the
second induction day onwards. Abdominal skin was dry,
with yellowish/brown crusts and desquamation seen
especially in inguinal areas and on upper hind limbs.
Only very gentle tape-stripping was required in order to
produce shiny abdominal skin, and in some mice with
these lesions, tape stripping was not performed when evi-
dently painful (manifested by shrill vocalising and strug-
gling). These lesions did not appear to be chronically
painful when not disturbed, as affected mice were
observed to be eating, sleeping and using their exercise
wheel. More severely affected mice walked with an unu-
sual gait, holding their abdomens clear from cage bed-
ding. This was presumably in order to avoid contact by
wood shavings with encrusted lesions, which, when dis-
lodged, resulted in blood or serous fluid oozing from
exposed skin. Healing was very rapid after induction dos-
ing was complete; by the completion of the experiments
at re-challenge (day 17), abdominal skin appeared essen-
tially normal, with minor residual scarring seen on two
animals.
Histopathology
1st examiner
Test ears from two mice dosed with 0.1% DNCB were
described as presenting with hyperaemia, infiltration of
inflammatory cells – mainly mononuclear cells with occa-
sional polymorphonuclear leukocytes (PMNs); dilated
lymphatic vessels and oedema (increased space between
connective tissue). Typical findings from the test ears of
test mice dosed with cylindrospermopsin were: oedema,
thickening, and inflammatory cell infiltration – mainly
mononuclear cells, though varying degrees of PMN infil-
tration were also seen. One test ear slide showed an epi-
dermal lesion, with hyperkeratinisation and associated
PMN infiltration. The overall impression was of mostly
mild inflammatory reactions to cylindrospermopsin, with
occasionally more severe effects. No pathological changes
were seen in any of the organs (liver, spleen, kidney, lung)
Point plot showing individual mouse ear thickness changes:  DNCB MEST (positive control experiment) Figure 1
Point plot showing individual mouse ear thickness changes: 
DNCB MEST (positive control experiment).
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Point plot showing individual mouse ear thickness changes: cylindrospermopsin MEST Figure 3
Point plot showing individual mouse ear thickness changes: cylindrospermopsin MEST.
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Point plot showing individual mouse ear thickness changes: C. raciborskii MEST (suspension contained 73 µg/mL CYN) Figure 2
Point plot showing individual mouse ear thickness changes: C. raciborskii MEST (suspension contained 73 µg/mL CYN).
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Table 1: Mouse ear swelling tests (MESTs): positive control + three cyanobacteria suspensions + purified cylindrospermopsin
TEST MATERIAL Proportion of test 
mice with ear 
swelling >20% 
after challenge
Proportion of 
test mice with 
ear swelling >20% 
after re-challenge
Per cent ear swelling 
of test group after 
challenge. Median 
(range)
Per cent ear swelling 
of test group after re-
challenge. Median 
(range)
Per cent ear swelling of 
highest responder control 
mouse after challenge and 
re-challenge
Fisher's exact test comparing 
proportion of ear thickness 
increases <20% between test 
and control mice
0.1% DNCB 100% n= 10 at 24 hrs
n = 9 at 24 & 48 hrs
Not done 68.6 (16.4 – 130.0) Not done Not done
2% w/v M. aeruginosa
microcystins 13.6 µg/mL
0 0 1.9 (-11.6 – 10.7) 1.2 (-1.6 – 10.0) 8.9
2% w/v A. circinalis saxi-
toxins 6.0 µg/mL
0 0 0.0 (-6.8 – 8.2) 1.5 (-2.9 – 9.5) 11.7
2% w/v C. raciborskii
cylindrospermopsin 73
µg/mL
60%
n= 2 at 24 hrs
n= 4 at 48 hrs
60%
n = 6 at 24 hrs
n = 2 at 24 & 48 hrs
15.8 (0.0 – 38.9) 18.3 (2.2 – 47.5) 10.7 p = 0.001
100 µg/mL
cylindrospermopsin*
22%
n = 1 at 24 hrs
n = 1 at 48 hrs
44%
n = 1 at 24 hrs
n = 3 at 48 hrs
8.1 (-4.8 – 26.1) 12.6 (4.5 – 49.2) 4.8 (challenge)
27.8 (re-challenge)
p = 0.51 (challenge)
p = 0.58 (rechallenge)
* challenge concentration applied to test ears was 50 µg/mL. Rechallenge concentration was 100 µg/mL (= induction concentration).BMC Dermatology 2006, 6:5 http://www.biomedcentral.com/1471-5945/6/5
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from mice cutaneously exposed to C. raciborskii suspen-
sion or cylindrospermopsin.
2nd examiners
Test ears from the two mice dosed with DNCB were
described as inflamed, and rated "+++". One ear from a
cylindrospermopsin-challenged mouse was rated "+++
with eosinophilia", and a control ear (i.e. vehicle-only
treated) from another cylindrospermopsin-challenged
mouse was rated "++ with some eosinophils". Again, liver,
kidney, lung and spleen tissues from all six mice dosed
with C. raciborskii suspension or purified cylindrosper-
mopsin were reported as normal.
Measures of inter-rater agreement
Table 2 presents results of microscopy examinations cate-
gorised into positive, negative and equivocal findings.
There was no difference in the marginal distributions of
the categories between raters (p = 0.35) and there was
excellent agreement beyond chance (κ = 0.83, 95% confi-
dence interval: 0.61, 1.0).
Figures 6 and 7 are examples of histopathology findings.
Both slides (test ear and control ear) were prepared from
ears taken from the same mouse. Note the test ear inflam-
matory cell infiltrate, thickening of dermal structures and
the area of epithelial hyperplasia.
Discussion
Before commencing these studies we conducted modified
MEST experiments to investigate primary irritant reac-
tions, as described by Patrick et al [25] and Patrick et al
[26]. We examined responses to suspensions of M. aerugi-
nosa  (QH/NR/Ma/03, 5%w/v lyophilised cells in 75%
methanol) and A. circinalis (non-toxic bloom sample,
Gordonbrook Dam, Queensland; 10% w/v in 75% meth-
anol). These were highly concentrated cyanobacterial
preparations, being about the maximum amounts of
lyophilised cyanobacteria that could produce viscous sus-
pensions. No positive findings were observed or meas-
ured (data not presented).
Both MESTs for DCH using toxic M. aeruginosa and A.
circinalis suspensions were unremarkable in all respects;
no abnormality was seen on either abdominal or ear skin,
and no ear thickness measurements were greater than the
threshold 20% increase. Therefore we did not proceed
with any further investigations into the cutaneous effects
of the cyanotoxins produced by these cyanobacterial iso-
lates (MC-LR and saxitoxins respectively).
The MEST to investigate C. raciborskii was, by contrast, a
very different experimental outcome. It became clear on
day three of induction dosing, i.e. some 72 hours after the
first induction dose, that a positive reaction was occurring.
Dry, encrusted lesions were seen on the abdomens of all
test animals – and on no control animals – from day three
onwards. No abnormalities were seen on day one, i.e. 24
hours after the first dose. No observations were taken on
day two, following the second induction dose, so it is not
known whether these abdominal lesions would have
been apparent any earlier than when first observed at 72
hours, following two dosings at 0 and 24 hours. Aware of
Table 2: Histopathology results – mouse ear swelling test
1st examiner (author AAS)
Positive Normal Uncertain Total
Positive 7 0 0 7
2nd examiners 
(DW & IR)
Normal 2 21 2 25
Uncertain 0 0 0 0
Total 9 21 2 32
Reaction seen at induction phase – cylindrospermopsin 100  µg/mL in 70% ethanol. Figure 4
Reaction seen at induction phase – cylindrospermopsin 100 
µg/mL in 70% ethanol.
Cylindrospermopsin MEST control mouse at induction phase  – dosed with vehicle (70% ethanol) Figure 5
Cylindrospermopsin MEST control mouse at induction phase 
– dosed with vehicle (70% ethanol)BMC Dermatology 2006, 6:5 http://www.biomedcentral.com/1471-5945/6/5
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the possibility that the reactions seen on abdominal skin
would also be found on the test ears of control (i.e. naïve
to C. raciborskii) mice, thus invalidating the MEST, we
decided to proceed with the test. No such reaction was
seen (see Table 1) in any of the ten control mice used in
challenge and rechallenge tests, thus confirming the find-
ings of Gad [19], who notes that a concentration of test
material that is irritating to one site – abdomen or ear –
may not be an irritant concentration for the other. Irritant
concentrations for ears are frequently higher than concen-
trations that will irritate abdominal skin [18]. Therefore
this MEST has shown that a 2%w/v suspension of cylin-
drospermopsin-producing C. raciborskii produces both a
primary irritant reaction on mouse abdominal skin, and
delayed-contact hypersensitivity. Unilateral erythema and
swelling was seen on the ears of some test mice, similar to
but of lesser intensity than the reactions seen on positive
control MEST mice dosed with 0.1% DNCB. No such reac-
tions were seen on any control mouse ears. No signs of
cutaneous injury similar to that seen on abdominal skin
were observed on any ears. Reactions were more pro-
nounced after rechallenge compared to challenge read-
ings, as shown in Table 1 and Figure 2.
Another MEST experiment using purified cylindrosper-
mopsin was conducted, to investigate further the findings
from the C. raciborskii MEST. The concentration was
higher than the measured concentration of cylindrosper-
mopsin in the 2% C. raciborskii suspension (100 µg/mL cf.
73 µg/mL), so when irritant reactions on the abdominal
skin of test mice were seen during the induction phase, the
possibility that irritant reactions might be induced on the
test ears of control mice, thus invalidating the experiment,
again needed to be considered. Therefore the challenge
concentration of cylindrospermopsin was reduced to 50
µg/mL (i.e. half that of the induction dose). Rechallenge
was conducted with the induction concentration of 100
µg/mL, but one of six control mice produced an ear swell-
ing of 28%, therefore no clear statement can be made
about these MEST rechallenge readings, as 100 µg/mL
cylindrospermopsin is most likely an irritant dose for the
mouse ear. The effect size for the CYN MEST (control
mice: p1 = 0/5 = 0; test mice: p2 = 2/9 = 0.22) indicates
that the statistical power to determine a significant differ-
ence of this size is less than 5%.
Reactions seen on abdominal skin in the cylindrosper-
mopsin MEST were identical to those seen during the C.
raciborskii MEST. Again, all test mice had visible lesions to
varying degrees. Healing was rapid after the final induc-
tion dose on day 5, so that by day 8, one mouse had a
residual dry scab on the abdomen, and the remaining
eight mice had essentially normal looking abdominal
skin. Because of the different challenge dose used in the
cylindrospermopsin MEST and the probable irritant reac-
tions seen at rechallenge, it is not possible to make confi-
dent predictions about the relative contribution of
cylindrospermopsin to the reactions seen in the C. racibor-
skii MEST.
The number of mice used in the CYN MEST was too small
to detect a statistically significant difference between pro-
portions of test and control mice achieving the threshold
ear thickness increases after challenge alone. However, the
gross similarity of reactions seen on abdominal skin in
both tests, and the fact that two test mice in the CYN MEST
challenge test met the methodological criteria of Gad [19]
for delayed-contact hypersensitivity (i.e. a statistically
non-significant but biologically significant finding) sug-
gests that cylindrospermopsin is the major contributor to
the outcome of the C. raciborskii MEST.
There are several specific points of departure when
attempting to apply the results of these findings to assess-
ing the risk for humans in recreational or occupational
contact with cylindrospermopsin-producing cyanobacte-
Cylindrospermopsin MEST, test ear Figure 7
Cylindrospermopsin MEST, test ear.
Cylindrospermopsin MEST, control ear (vehicle only) Figure 6
Cylindrospermopsin MEST, control ear (vehicle only).BMC Dermatology 2006, 6:5 http://www.biomedcentral.com/1471-5945/6/5
Page 10 of 12
(page number not for citation purposes)
ria. These being the concentration of cylindrospermopsin
was well above that likely to be encountered in natural
waters (see following discussion); barrier function was
disrupted by tape-stripping during the induction phase
(removal of the stratum corneum by tape-stripping stim-
ulates the release of pre- formed IL-1α and other inflam-
matory cytokines from the epidermis [27,28]); a vehicle
(70% ethanol) was used to aid the transport of soluble
factors across the epidermis (matrix effects can be highly
significant determinants of the potency of allergens, with
reported variability of more than two orders of magnitude
due to different vehicles [29]); and mice were immuno-
logically primed to respond to sensitisers by use of Fre-
und's adjuvant and hypervitaminosis-A (vitamin A
induces epidermal hyperplasia in mice; most cell-medi-
ated immune responses are stimulated by vitamin-A sup-
plementation [30]). However, the main aim of
conducting animal models in this kind of exploratory
work was to determine whether the mechanism of irri-
tancy and hypersensitivity was feasible with these cyano-
bacterial preparations. Further investigation to determine
dose-response relationships and cellular and molecular
mechanisms should follow from this work.
Histopathology
Histopathology findings apparently revealed three false
positive readings: firstly, the test ears from two control
mice tested with 100 µg/mL purified cylindrospermopsin
at rechallenge, i.e. test material applied to naïve mice.
However, from Table 1 and Figure 3 it seems clear that the
rechallenge CYN concentration of 100 µg/mL was an irri-
tant dose for at least one mouse, as determined by an ear
thickness increase greater than 20 per cent. Both patholo-
gists rated the same two test ears as positive from this
group of five control mice. One of these "false positive"
test ears was from the mouse that produced a 28% differ-
ence in ear thickness after rechallenge (Table 1 & Figure
3). Therefore, because both examiners rated the same two
ears as having a positive reaction, and the dose applied to
the ears of these naïve mice was probably in the irritant
range, the most likely interpretation is that these were not
false positive readings but true positive findings. The 1st
examiner described the slide from the mouse producing
the 28% ear swelling reading as having "oedema, mild
inflammatory infiltrate, with some polymorphs", and the
2nd examiner group rated this ear at "+++".
The other "false positive" reading is from a control ear, i.e.
dosed with vehicle only. The 1st examiner was twice pre-
sented with this slide; he reported it positive on both occa-
sions, describing it as oedematous, with polymorph
infiltration. The 2nd examiner group also described this
slide as positive, rating it "++ with some eosinophils".
Therefore, it would appear that this slide also represented
true positive histopathology. Ear thickness measurements
on this mouse throughout the MEST procedure were
always positive, i.e. the test ear consistently produced
higher micrometer readings than the control ear in ques-
tion. Care was taken during the MEST procedure to pre-
vent incorrect dosing of test and control ears: the test ears
of all mice in each MEST were dosed and dried, then the
container with the test suspension or solution was sealed,
the container tube for the vehicle was opened, and each
mouse was taken from its cage for dosing of control ears.
The histopathology of the test ear from this mouse was
also clearly positive: the 1st examiner described it as hav-
ing cellular proliferation, polymorphs and mononuclear
cells and oedema; the 2nd examiner group rated this test
ear at "+++".
No positive histopathology was seen in test ears of mice
from the A. circinalis and M. aeruginosa MESTs; this sup-
ports the negative findings of both those MESTs. In con-
clusion, the histopathology findings correlate well with
the MEST results, and the two independent pathologist
examinations demonstrate excellent agreement.
Relative sensitising potency of cylindrospermopsin
Understanding the relative potency of a toxin is an impor-
tant step in defining the associated public health risk. This
also applies to safety assessments of skin sensitisers,
which may vary up to 10,000-fold in sensitising potency
[31]. The induction and sensitisation concentrations of
CYN in the C. raciborskii and CYN MESTs (50, 73 and 100
µg/mL) were artificially high, with field concentrations in
lakes and ponds typically less than 1 mg/L [32-34]. How-
ever, when considering these concentrations in the con-
text of thresholds for sensitising chemicals proposed by
the European Centre for Ecotoxicology and Toxicology of
Chemicals (ECETOC) [31], 50 µg/mL (0.005%w/v) and
100 µg/mL (0.01%w/v) are in the range of concentrations
to be classified as "extreme" sensitisers. Therefore, DCH
generated by CYN at any concentration below those used
in these MESTs will, by the ECETOC rating [31], still place
cylindrospermopsin in the category of an extremely
potent sensitiser.
Threshold concentrations can be determined for chemical
sensitisers, and dose-response relationships are apparent
in both induction and sensitisation phases [[29,31,35]
(pp.2, 3, 17)]. If dose-response studies show that cylin-
drospermopsin is capable of eliciting DCH at lower con-
centrations than the artificially high doses used in these
experiments, the appropriate question will be whether
CYN at naturally occurring levels is below the threshold
for DCH – and irritant reactions.
Summary and conclusion
Using a mouse model of delayed-contact hypersensitivity,
we have demonstrated that both a cylindrospermopsin-BMC Dermatology 2006, 6:5 http://www.biomedcentral.com/1471-5945/6/5
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containing suspension of C. raciborskii and purified cylin-
drospermopsin elicit irritant and hypersensitivity reac-
tions. Toxin-producing suspensions of M. aeruginosa and
A. circinalis failed to induce any observable or measurable
adverse reactions. All three sonicated preparations were
applied to mouse skin at identical concentrations (2%w/
v lyophilised cyanobacteria). Further experimental work
should follow in order to confirm positive and negative
findings of this study and previously published work.
Studies of the cellular and molecular processes involved
in the cutaneous toxicity of cylindrospermopsin would be
of great interest.
Cylindrospermopsin-producing cyanobacteria are widely
distributed in tropical, subtropical and temperate waters
of all continents. Public health authorities and recrea-
tional water managers are aware of the potential for harm
through accidental or deliberate ingestion of water con-
taminated by cylindrospermopsin; authorities may also
need to consider the potential for cylindrospermopsin-
producing cyanobacteria to be associated with complaints
of acute skin reactions.
Abbreviations
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DCH delayed-contact hypersensitivity
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